For the Inventor, By the Inventor

Enter inventor name

Pran Kishore Deb

This inventor holds 28 USPTO granted patents, primarily in Antibacterial Agents. Top assignee: King Faisal University. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pran Kishore Deb. Retrieved from https://idiyas.com/inventor/pran-kishore-deb-zc2tkpgd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28

% Patents Active = 100.0

Average Co-Inventor Count = 7.3

ph-index = 1

Location History:

Ranchi, IN (2023 - 2024)
Mesra, IN (2024)

Company Filing History:

King Faisal University

Years Active: 2023-2025

Loading Chart...

Areas of Expertise:

Antibacterial Agents

Anti-Tubercular Agents

Pyrimidine Derivatives

COX-2 Inhibitors

Anti-Inflammatory Agents

Larvicidal Agents

Anticancer Agents

Thieno-Pyrimidines

Oxadiazole Derivatives

Quinoline Derivatives

Indolizine Derivatives

Triazole Derivatives

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297204 - 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents (2025-05-13),

2. 12227516 - Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide as anti-inflammatory agents (2025-02-18),

3. 12227480 - 1-(2-(substituted phenyl)-2-oxoethyl)-4-methylpyridin-1-ium bromide as anti-tubercular agents (2025-02-18),

4. 12221450 - 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents (2025-02-11),

5. 12215082 - (e)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides as antitubercular agents (2025-02-04),

6. 12187733 - 5-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents (2025-01-07),

7. 12172973 - (E)-2-(3-Cyano-4-isobutoxyphenyl)-N'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents (2024-12-24),

8. 12145915 - (E)-2-(3-cyano-4-isobutoxyphenyl)-n'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents (2024-11-19),

9. 11998532 - Substituted 1,3,4-oxadiazole derivatives as anti-tubercular agents (2024-06-04),

10. 11987563 - 3-cyano 4,5-diphenyl furan-2-carboxamides as antitubercular agents (2024-05-21),

11. 11986476 - (6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents (2024-05-21),

12. 11981674 - 7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as larvicidal agents (2024-05-14),

13. 11981643 - Oxoimidazolidine derivatives as anti-tubercular agents (2024-05-14),

14. 11976066 - Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents (2024-05-07),

15. 11974991 - Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates (2024-05-07),

Title: Pran Kishore Deb - The Innovative Mind from Ranchi

Introduction: Pran Kishore Deb is a renowned inventor hailing from Ranchi, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Pran Kishore Deb holds several patents in various technological domains, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Pran Kishore Deb has worked with leading tech companies, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Throughout his career, Pran Kishore Deb has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and knowledge sharing.

Conclusion: Pran Kishore Deb's passion for innovation and his relentless drive to create have solidified his position as a trailblazer in the world of technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…